Deucravacitinib in Japanese patients with plaque, generalized pustular, or erythrodermic psoriasis: Patient-reported outcomes in the POETYK PSO-4 study

By sjmartinez • December 7, 2024

Tada Y, Armstrong AW, Imafuku S, Okubo Y, Morita A, Zhong Y, Zhuo J, Becker B, Napoli A, Banerjee S, Ohtsuki M. Deucravacitinib in Japanese patients with plaque, generalized pustular, or erythrodermic psoriasis: Patient-reported outcomes in the POETYK PSO-4 study. J Dermatol. 2024 Dec 6. doi: 10.1111/1346-8138.17570. Epub ahead of print. PMID: 39641509.

Tags: Clinical Trial, Dermatology, patient‐reported outcome measures, psoriasis, Publications, Quality of Life, Treatment outcome

Clarifying Psoriasis Disease Severity: A Position Statement from the National Psoriasis Foundation Medical Board

Blauvelt A, Prussick R, Merola JF, Shahriari M, Cather J, Eakin GS, McCormick Howard L, Lebwohl MG, Armstrong AW, Duffin KC. Clarifying Psoriasis Disease Severity:[...]

Dermatofibrosarcoma Protuberans of the Clavicular Skin in a 70-Year-Old Woman: Case Report and Management

Peng DS, Shen A, Kang Y, Yamamoto RK, Levins P. Dermatofibrosarcoma Protuberans of the Clavicular Skin in a 70-Year-Old Woman: Case Report and Management. Cureus.[...]

Helicobacter pylori as a risk factor for pemphigus and pemphigoid: A US large-scale cohort study using the TriNetX database

Kasperkiewicz M, Ludwig RJ, Curman P. Helicobacter pylori as a risk factor for pemphigus and pemphigoid: A US large-scale cohort study using the TriNetX database.[...]